An accomplished business leader and executive officer in the medical device industry, Jeffrey Greiner currently holds the position of CEO of Valencia Technologies Corporation. Prior to founding Valencia Technologies in 2010, he led Advanced Bionics, where in his 18 years with the firm he rose from chief operating officer to president to chief executive officer. Jeffrey Greiner played a key role in taking Advanced Bionics from its spin-off stage to a 300 million-dollar operation specializing in creating devices that allow deaf people around the world to hear. In addition, he eventually oversaw the split-up and multibillion-dollar sale of the company, which today is owned by the firms of Boston Scientific and Sonova.
In his position at Valencia Technologies, Jeff Greiner oversees the development and manufacture of disruptive neuromodulation technologies used in the treatment of major chronic conditions. Beginning in July of 2013, he and his colleagues will manage a comprehensive feasibility clinical trial that involves medical centers worldwide.
Before beginning his career leading medical companies, Jeff Greiner earned a juris doctor from the UCLA (University of California, Los Angeles) Law School and a master of laws from George Washington University Law School. From the late 1970s to the late 1980s, Mr. Greiner served in the United States Air Force, during which time he functioned as an assistant judge advocate, a judge advocate, and the chief military counsel in Japan and Korea. Greiner received his bachelor of science degree in economics from the United States Air Force Academy.